Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Developing adaptive treatment strategies in substance abuse research.

Murphy SA, Lynch KG, Oslin D, McKay JR, TenHave T.

Drug Alcohol Depend. 2007 May;88 Suppl 2:S24-30. Epub 2006 Oct 23.

2.

A "SMART" design for building individualized treatment sequences.

Lei H, Nahum-Shani I, Lynch K, Oslin D, Murphy SA.

Annu Rev Clin Psychol. 2012;8:21-48. doi: 10.1146/annurev-clinpsy-032511-143152. Epub 2011 Dec 12. Review.

3.

A SMART design to optimize treatment strategies for patient and family caregiver outcomes.

Song MK, DeVito Dabbs A, Ward SE.

Nurs Outlook. 2016 Jul-Aug;64(4):299-305. doi: 10.1016/j.outlook.2016.04.008. Epub 2016 May 7.

PMID:
27264454
4.

SMARTer discontinuation trial designs for developing an adaptive treatment strategy.

Almirall D, Compton SN, Rynn MA, Walkup JT, Murphy SA.

J Child Adolesc Psychopharmacol. 2012 Oct;22(5):364-74. doi: 10.1089/cap.2011.0073.

5.

Using engineering control principles to inform the design of adaptive interventions: a conceptual introduction.

Rivera DE, Pew MD, Collins LM.

Drug Alcohol Depend. 2007 May;88 Suppl 2:S31-40. Epub 2006 Dec 13.

6.
7.

Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.

Almirall D, Compton SN, Gunlicks-Stoessel M, Duan N, Murphy SA.

Stat Med. 2012 Jul 30;31(17):1887-902. doi: 10.1002/sim.4512. Epub 2012 Mar 22.

8.

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?

Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S97-112. doi: 10.1016/j.jsat.2010.01.012.

9.

Randomization in substance abuse clinical trials.

Hedden SL, Woolson RF, Malcolm RJ.

Subst Abuse Treat Prev Policy. 2006 Feb 6;1:6. Review.

10.

Comparing dynamic treatment regimes using repeated-measures outcomes: modeling considerations in SMART studies.

Lu X, Nahum-Shani I, Kasari C, Lynch KG, Oslin DW, Pelham WE, Fabiano G, Almirall D.

Stat Med. 2016 May 10;35(10):1595-615. doi: 10.1002/sim.6819. Epub 2015 Dec 6.

11.

Choosing a control group in effectiveness trials of behavioral drug abuse treatments.

Brigham GS, Feaster DJ, Wakim PG, Dempsey CL.

J Subst Abuse Treat. 2009 Dec;37(4):388-97. doi: 10.1016/j.jsat.2009.05.004. Epub 2009 Jun 23.

12.

Costs and effectiveness of substance abuse treatments for homeless persons.

Schumacher JE, Mennemeyer ST, Milby JB, Wallace D, Nolan K.

J Ment Health Policy Econ. 2002 Mar;5(1):33-42.

PMID:
12529568
13.

Developing and testing adaptive treatment strategies using substance-induced psychosis as an example.

Dawson R, Green AI, Drake RE, McGlashan TH, Schanzer B, Lavori PW.

Psychopharmacol Bull. 2008;41(3):51-67.

14.

Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects.

Dai T, Shete S.

BMC Med Res Methodol. 2016 Aug 30;16(1):112. doi: 10.1186/s12874-016-0202-7.

15.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

16.

Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.

Potter JS, Donovan DM, Weiss RD, Gardin J, Lindblad R, Wakim P, Dodd D.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):400-7. doi: 10.3109/00952990.2011.596975.

17.

Flexible treatment strategies in chronic disease: clinical and research implications.

Lavori PW, Dawson R, Rush AJ.

Biol Psychiatry. 2000 Sep 15;48(6):605-14. Review.

PMID:
11018231
18.

Ethical pitfalls in neonatal comparative effectiveness trials.

Modi N.

Neonatology. 2014;105(4):350-1. doi: 10.1159/000360650. Epub 2014 May 30.

PMID:
24931328
19.

Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.

Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR.

Contemp Clin Trials. 2012 Mar;33(2):386-95. doi: 10.1016/j.cct.2011.11.001. Epub 2011 Nov 9.

20.

A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders.

Nahum-Shani I, Ertefaie A, Lu XL, Lynch KG, McKay JR, Oslin DW, Almirall D.

Addiction. 2017 May;112(5):901-909. doi: 10.1111/add.13743. Epub 2017 Feb 18.

PMID:
28029718

Supplemental Content

Support Center